Champions Oncology (CSBR) Gross Margin (2017 - 2026)
Champions Oncology (CSBR) posted Gross Margin of 50.78% for Q2 2026, up 8.84% on a QoQ basis from 46.65% in Q1 2026, and up 963.0% year-over-year from 4.78% in Q2 2025.
Powered by 
Analysis
Champions Oncology (CSBR) Gross Margin (2017 - 2026) Analysis & Trends
Champions Oncology has reported Gross Margin for 10 years, with the latest figure at 50.78% in Q2 2026.
- On a quarterly basis, Gross Margin rose 963.0% year-over-year to 50.78% in Q2 2026; TTM through Apr 2026 was 48.0%, a 215.0% decrease from a year earlier, with the FY2026 full-year figure at 48.0%, down 214.0% from the prior year.
- Gross Margin was 50.78% for Q2 2026 at Champions Oncology, up from 46.65% in the prior quarter.
- The five-year high for Gross Margin was 61.17% in Q1 2025, with the low at 34.7% in Q1 2024.
- Average Gross Margin over 5 years is 46.49%, with a median of 47.27% recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: Gross Margin soared 2647 bps in 2025, then plunged 1451 bps in 2026.
- Over 5 years, Gross Margin stood at 47.88% in 2022, then decreased by 11 bps to 42.82% in 2023, then rose by 5 bps to 44.93% in 2024, then grew by 15 bps to 51.7% in 2025, then dropped by 2 bps to 50.78% in 2026.
- The last three Gross Margin figures came in at 50.78% (Q2 2026), 46.65% (Q1 2026), and 51.7% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 32.85% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 28.51% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 45.02% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 23.23% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 20.52% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 91.47% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 50.78% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 60.63% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 50.78% |
| Jan 31, 2026 | 46.65% |
| Oct 31, 2025 | 51.70% |
| Jul 31, 2025 | 42.87% |
| Apr 30, 2025 | 41.15% |
| Jan 31, 2025 | 61.17% |
| Oct 31, 2024 | 44.93% |
| Jul 31, 2024 | 49.70% |
| Apr 30, 2024 | 48.22% |
| Jan 31, 2024 | 34.70% |
| Oct 31, 2023 | 42.82% |
| Jul 31, 2023 | 38.83% |
| Apr 30, 2023 | 43.86% |
| Jan 31, 2023 | 39.72% |
| Oct 31, 2022 | 47.88% |
| Jul 31, 2022 | 48.69% |
| Apr 30, 2022 | 51.69% |
| Jan 31, 2022 | 51.44% |
| Oct 31, 2021 | 52.41% |
| Jul 31, 2021 | 52.05% |